Joshua Mitchell
@joshmitchellmd
Followers
436
Following
897
Statuses
242
Cardiologist at Washington University in St. Louis. #CardioOnc, evidence-based medicine, prevention, patient advocacy. Army veteran (#RLTW). Opinions my own.
St Louis, MO
Joined April 2013
RT @BKopeckyMDPhD: 3 years ago my good friend @MorenoMDPhD approached me about this crazy idea to fill a much needed gap in heart failure e…
0
13
0
Congrats to Matt Lui, outstanding @WashUCardiology fellow, on his study showing that a visual review of CAC on NSCLC RAD planning CT was more predictive of CV events than Rad dose. Visual review ~ formal CAC score. #cardioonc @ICOSociety @SBRT_CR
0
10
20
Congrats to @RajaZaghlol for leading our contemporary review of CV complications from radiation therapy including historic trends and current recs. Always great to work with @carmenbergom @DrLPedersen and @yoo_sgkyle! #cardioonc @WashUCardiology
1
11
23
Congrats to @gwalls89 for an excellent manuscript detailing the practice patterns and general uptake of guidelines in #radonc internationally. Interesting insights! #cardioonc @icosociety @gerryhanna
0
6
14
Awesome work by @RajaZaghlol exploring the CV effects of CAR-T in the Medicare population. Well-deserved! Special thanks to @kejoynt, @dgermain21 and Elena Deych, among others as well! Looking forward to the manuscript! @WashUCardiology #cardioonc
Proud to be selected as a YIA finalist in the #GCOS2024 presenting our work investigating MACE in older adults receiving CART therapy. Special thanks to @joshmitchellmd for exceptional mentoring. @ICOSociety
0
2
10
RT @AnaBaracCardio: Huge Congratulations w Thank you @JLiu_MSKCardOnc & @DrGuptaD! Phenomenal #MSKCardioOnc meeting moving #CardioOnc forwa…
0
3
0
@DrSFeldman @MSKCME @genomics212 Thanks @DrSFeldman ! You have all planned an amazing symposium!!!! Glad I could contribute!
0
0
2
Excellent symposium on #cardionc with a nice balance of presentations on the breadth of the field. Congrats to @JLiu_MSKCardOnc and @DrGuptaD and the rest of the planning committee. #mskcardionccme @MSKCancerCenter @WashUCardiology
Masterful review of radiation heart disease and optimal strategies for surveillance by @joshmitchellmd #MSKCardioOncCME @MSKCME @genomics212
0
0
14
Look forward to seeing everyone on Saturday for a packed agenda on #amyloidosis! Great speakers from @WUSTLmed and @PennMedicine as well as our esteemed grad @CampbellMDPhD! Free registration for trainees and patients/families. @Amyloidosisfdn @CyclingDoctor @WashUCardiology
The Continuing Medical Education - Amyloidosis 2024: Update on Best Practices for Early Detection and Treatment - will be Saturday, April 27th. It's designed for healthcare providers involved in the diagnosis or management of amyloidosis. @WUSTLmed Info>
0
5
16
Great partnering with @myocardialsoln + the team on this important study. MRI myocardial strain is the most sensitive way to detect early cardiotoxicity. Excited to determine how early detection can best guide cardioprotection to improve heart health. @WashUCardiology #cardioonc
0
3
16
RT @WashUCardiology: Register now for @WUSTLmed @WUDeptMedicine Amyloidosis 2024 Symposium on April 27th- free for trainees! For details…
0
4
0
RT @HanZhuMD: Excited to share this preprint. Serial, routine troponin-I screening in 428 consecutive patients treated with immunotherapy a…
0
13
0
RT @CyclingDoctor: Published in @Heart_BMJ --"Moving towards establishing centres of excellence in cardiac amyloidosis: an International Ca…
0
11
0
Great having the chance to talk #cardioonc education with @nickwilcox, @vgzmd, @BenedicteLefeb1 and @JACCJournals. Check out the podcast below. 👇 #jacccardioonc @WashUCardiology @WUSTLmed
0
1
10
RT @WashUCardiology: New Podcast from @JACCJournals Cardio-OncologyPulse featuring Dr. Joshua Mitchell, @joshmitchellmd highlighting educat…
0
1
0
RT @Richardkcheng2: Is apical sparing on echo sufficient for the diagnosis of cardiac amyloidosis? In this multicenter study, we identifie…
0
27
0
Unfortunately, the initial published graphic was hard to interpret. The updated graphic (same link) now more clearly shows the significant difference in CV events across cancer types. Take a look!
It's incredible to visualize the prevalence of CV risk factors across cancers, and the high rate of CV events in lung cancer especially. Work to do! Congrats to the team! @wustlmed @WashUCardiology #cardioonc @icos Dan Lenihan @ScienceAtBMS
0
1
4
RT @LilySternMD: 1/ Check out our recent publication in @JCardFail ! The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and…
0
17
0
It's incredible to visualize the prevalence of CV risk factors across cancers, and the high rate of CV events in lung cancer especially. Work to do! Congrats to the team! @wustlmed @WashUCardiology #cardioonc @icos Dan Lenihan @ScienceAtBMS
1
17
46
RT @avirupguha: Excellent group of friends and colleagues from around the world. @DrTochiOkwuosa @md_addison @mariellesc1 @DSadlerMD @A_Ste…
0
9
0